AQR Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-78,988
Closed -$240K 3226
2024
Q4
$240K Sell
78,988
-20,199
-20% -$61.4K ﹤0.01% 2599
2024
Q3
$515K Sell
99,187
-101,893
-51% -$529K ﹤0.01% 2160
2024
Q2
$517K Buy
201,080
+170,960
+568% +$439K ﹤0.01% 2040
2024
Q1
$148K Buy
+30,120
New +$148K ﹤0.01% 2301
2023
Q3
Sell
-13,483
Closed -$341K 2398
2023
Q2
$341K Sell
13,483
-717
-5% -$18.1K ﹤0.01% 1900
2023
Q1
$457K Buy
+14,200
New +$457K ﹤0.01% 1810
2021
Q4
Sell
-9,691
Closed -$270K 2297
2021
Q3
$270K Hold
9,691
﹤0.01% 2063
2021
Q2
$287K Sell
9,691
-6,517
-40% -$193K ﹤0.01% 2055
2021
Q1
$453K Sell
16,208
-1,386
-8% -$38.7K ﹤0.01% 1872
2020
Q4
$499K Sell
17,594
-2,547
-13% -$72.2K ﹤0.01% 1790
2020
Q3
$506K Buy
20,141
+6,838
+51% +$172K ﹤0.01% 1716
2020
Q2
$325K Buy
+13,303
New +$325K ﹤0.01% 1869
2018
Q4
Sell
-8,086
Closed -$201K 2297
2018
Q3
$201K Sell
8,086
-5,163
-39% -$128K ﹤0.01% 2194
2018
Q2
$364K Buy
13,249
+39
+0.3% +$1.07K ﹤0.01% 2076
2018
Q1
$407K Buy
13,210
+356
+3% +$11K ﹤0.01% 1970
2017
Q4
$460K Buy
12,854
+2,463
+24% +$88.1K ﹤0.01% 1941
2017
Q3
$286K Buy
+10,391
New +$286K ﹤0.01% 2092
2016
Q3
Sell
-12,073
Closed -$164K 2303
2016
Q2
$164K Sell
12,073
-3,114
-21% -$42.3K ﹤0.01% 2127
2016
Q1
$265K Buy
15,187
+2,666
+21% +$46.5K ﹤0.01% 2037
2015
Q4
$428K Buy
+12,521
New +$428K ﹤0.01% 1930